A Scoping Review of Gut Microbiome and Bifidobacterium Research in Zimbabwe: Implications for Future Studies

References

• Iddrisu I, Monteagudo-Mera A, Poveda C, et al. Malnutrition and gut microbiota in children. Nutrients. 2021;13(8):2727. doi:10.3390/nu13082727
   PubMed Web of Science ®Google Scholar
• Lin C, Lin Y, Zhang H, et al. Intestinal ‘infant-type’ bifidobacteria mediate immune system development in the first 1000 days of life. Nutrients. 2022;14(7):1498. doi:10.3390/nu14071498
   PubMed Web of Science ®Google Scholar
• Huda MN, Ahmad SM, Alam MJ, et al. Bifidobacterium abundance in early infancy and vaccine response at 2 years of age. Pediatrics. 2019;143:e20181489. doi:10.1542/peds.2018-1489
   PubMed Web of Science ®Google Scholar
• Saturio S, Nogacka AM, Alvarado-Jasso GM, et al. Role of bifidobacteria on infant health. Microorganisms. 2021;9(12):2415. doi:10.3390/microorganisms9122415
   PubMed Web of Science ®Google Scholar
• Wong CB, Iwabuchi N, Xiao J-Z. Exploring the science behind Bifidobacterium breve M-16V in infant health. Nutrient. 2019;11(8):1724. doi:10.3390/nu11081724
   PubMed Web of Science ®Google Scholar
• Cukrowska B, Bierła JB, Zakrzewska M, et al. The relationship between the infant gut microbiota and allergy. the role of bifidobacterium breve and prebiotic oligosaccharides in the activation of anti-allergic mechanisms in early life. Nutrients. 2020;12(4):946. doi:10.3390/nu12040946
   PubMed Web of Science ®Google Scholar
• He F, Ouwehand AC, Isolauri E, et al. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol. 2001;30(1):43–47. doi:10.1111/j.1574-695X.2001.tb01548.x
   PubMedGoogle Scholar
• Gotoh A, Katoh T, Sakanaka M, et al. Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum. Sci Rep. 2018;8(1):13958. doi:10.1038/s41598-018-32080-3
   PubMedGoogle Scholar
• O’Neill I, Schofield Z, Hall LJ, Marchesi JR. Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases. Emerging Top Life Sci 2017;1:333–349. doi:10.1042/ETLS20170058
   PubMedGoogle Scholar
• Kozak K, Charbonneau D, Sanozky-Dawes R, et al. Characterization of bacterial isolates from the microbiota of mothers’ breast milk and their infants. Gut Microbes. 2015;6(6):341–351. doi:10.1080/19490976.2015.1103425
   PubMed Web of Science ®Google Scholar
• Yakoob R, Pradeep BV. Bifidobacterium sp as probiotic agent - roles and applications. J Pure Appl Microbiol. 2019;13(3):1407–1417. doi:10.22207/JPAM.13.3.11
   Web of Science ®Google Scholar
• Phillips S, Watt R, Atkinson T, et al. on behalf of the PEARL study team, The Pregnancy and EARly Life study (PEARL) - a longitudinal study to understand how gut microbes contribute to maintaining health during pregnancy and early life, BMC. Pediatr. 2021;21:357.
   PubMed Web of Science ®Google Scholar
• Walsh C, Lane JA, van Sinderen D, et al. Human milk oligosaccharides: shaping the infant gut microbiota and supporting health. J Funct Foods. 2020;72:104074. doi:10.1016/j.jff.2020.104074
   PubMed Web of Science ®Google Scholar
• Lawson MAE, O’Neill IJ, Kujawska M, et al. Breast milk-derived human milk oligosaccharides promote Bifidobacterium interactions within a single ecosystem. ISME J. 2020;14(2):635–648. doi:10.1038/s41396-019-0553-2
   PubMed Web of Science ®Google Scholar
• Kostopoulos I, Elzinga J, Ottman N, et al. Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro. Sci Rep. 2020;10:14330. doi:10.1038/s41598-020-71113-8
   PubMed Web of Science ®Google Scholar
• Kijner S, Cher A, Yassour M. the infant gut commensal Bacteroides dorei presents a generalized transcriptional response to various human milk Oligosaccharides. Front Cell Infect Microbiol. 2022;12:854122. doi:10.3389/fcimb.2022.854122
   PubMed Web of Science ®Google Scholar
• Abrahamse-Berkeveld M, Alles M, Franke-Beckmann E, et al. Infant formula containing galacto-and fructo-oligosaccharides and Bifidobacterium breve M-16V supports adequate growth and tolerance in healthy infants in a randomised, controlled, double-blind, prospective, multicentre study. J Nutr Sci. 2016;5:e42. doi:10.1017/jns.2016.35
   PubMedGoogle Scholar
• Hidalgo-Cantabrana C, Delgado S, Ruiz L, et al. Bifidobacteria and their health-promoting effects. Microbiol Spectr. 2017;5(3). doi:10.1128/microbiolspec.BAD-0010-2016.
   PubMed Web of Science ®Google Scholar
• Tojo R, Suárez A, Clemente MG, et al. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol. 2014;20(41):15163–15176. doi:10.3748/wjg.v20.i41.15163
   PubMed Web of Science ®Google Scholar
• Jordan A, Carding SR, Hall LJ. The early-life gut microbiome and vaccine efficacy. Lancet Microbe. 2022;3:e787–94. doi:10.1016/S2666-5247(22)00185-9
   PubMedGoogle Scholar
• Alcon-Giner C, Dalby MJ, Caim S, et al. Microbiota supplementation with Bifidobacterium and Lactobacillus modifies the preterm infant gut microbiota and metabolome: an observational study. Cell Rep Med. 2020;1(5):100077. doi:10.1016/j.xcrm.2020.100077
   PubMedGoogle Scholar
• Laursen MF. Gut microbiota development: influence of diet from infancy to toddlerhood. Ann Nutr Metab. 2021;1–14. doi:10.1159/000517912
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021:372:n71. doi:10.1136/bmj.n71.
   Web of Science ®Google Scholar
• Gough EK, Prendergast AJ, Mutasa KE, et al. The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial team, assessing the intestinal microbiota in the SHINE Trial. Clin Infect Dis. 2015;61(suppl 7):S685–702. doi:10.1093/cid/civ850
   PubMedGoogle Scholar
• Gough EK, Edens TJ, Geum HM, et al. For SHINE trial team, maternal fecal microbiome predicts gestational age, birth weight and neonatal growth in rural Zimbabwe. EBiomedicine J. 2021;68:103421. doi:10.1016/j.ebiom.2021.103421
   PubMed Web of Science ®Google Scholar
• Robertson RC, Church JA, Edens TJ, et al. SHINE Trial Team, The fecal microbiome and rotavirus vaccine immunogenicity in rural Zimbabwean infants. Vaccine. 2021;39:5391–5400. doi:10.1016/j.vaccine.2021.07.076
   PubMed Web of Science ®Google Scholar
• Robertson RC, Edens TJ, Carr L, et al. The gut microbiome and early-life growth in a population with high prevalence of stunting. Nat Commun. 2023;14:654. doi:10.1038/s41467-023-36135-6
   PubMed Web of Science ®Google Scholar
• Smith LE, Chagwena DT, Bourke C, et al. Child Health, Agriculture and Integrated Nutrition (CHAIN): protocol for a randomised controlled trial of improved infant and young child feeding in rural Zimbabwe. BMJ Open Nutr Metab. 2021;12(12). doi:10.1136/bmjopen-2021-056435
   Google Scholar
• Flygel TT, Sovershaeva E, Claassen-Weitz S, et al. BREATHE study team, composition of gut microbiota of children and adolescents with perinatal human immunodeficiency virus infection taking antiretroviral therapy in Zimbabwe. The J of Infect Dis. 2020;221:3.
   Web of Science ®Google Scholar
• Osakunor DNM, Munk P, Mduluza T, et al. The gut microbiome but not the resistome is associated with urogenital schistosomiasis in preschool-aged children. Commun Biol J. 2020;3:155. doi:10.1038/s42003-020-0859-7
   PubMed Web of Science ®Google Scholar
• Kay GL, Millard A, Sergeant MJ, et al. Differences in the faecal microbiome in schistosoma haematobium infected children vs. uninfected children. PLoS Negl Trop Dis. 2015;9(6):e0003861. doi:10.1371/journal.pntd.0003861
   PubMed Web of Science ®Google Scholar
• Pfavayi LT, Sibanda EN, Baker S, et al. Fungal allergic sensitisation in young rural Zimbabwean children: gut mycobiome and seroreactivity characteristics. Curr Res Microb Sci. 2021;2(2021):100082. doi:10.1016/j.crmicr.2021.100082
   PubMedGoogle Scholar
• Katsidzira L, Ocvirk S, Wilson A, et al. Differences in fecal gut microbiota, short-chain fatty acids and bile acids link colorectal cancer risk to dietary changes associated with urbanization among Zimbabweans. Nutr Cancer. 2019;71:8. doi:10.1080/01635581.2019.1602659
   Web of Science ®Google Scholar
• Bourke CD, Gough EK, Pimundu G, et al. Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation. Sci Transl Med. 2019;11(486):eaav0537. doi:10.1126/scitranslmed.aav0537
   PubMed Web of Science ®Google Scholar
• Gough EK, Bourke CD, Berejena C, et al. Strain-level analysis of gut-resident pro-inflammatory viridans group Streptococci suppressed by long-term cotrimoxazole prophylaxis among HIV-positive children in Zimbabwe. Gut Microbes. 2020;11(4):1104–1115. doi:10.1080/19490976.2020.1717299
   PubMed Web of Science ®Google Scholar
• Duri K, Gumbo FZ, Munjoma PT, et al.; the UZ-CHS Birth Cohort Team. The University of Zimbabwe College of Health Sciences (UZ-CHS) BIRTH COHORT study: rationale, design and methods. BMC Infect Dis. 20;2020:725. doi:10.1186/s12879-020-05432-6
   PubMed Web of Science ®Google Scholar
• Chandiwana P, Munjoma PT, Mazhandu AJ, et al. Antenatal gut microbiome profiles and effect on pregnancy outcome in HIV infected and HIV uninfected women in a resource limited setting. BMC Microbiol. 2023;23:4. doi:10.1186/s12866-022-02747-z
   PubMed Web of Science ®Google Scholar
• Humphrey JH, Mbuya MNN, Ntozini R, et al. for the Sanitation Hygiene Infant Nutrition Efficacy (SHINE) Trial Team, Independent and combined effects of improved water, sanitation, and hygiene, and improved complementary feeding, on child stunting and anaemia in rural Zimbabwe: a cluster-randomised trial. The Lancet Global Health J. 2019. doi:10.1016/S2214-109X(18)30374-7
   Google Scholar
• Holzhausen EA, Nikodemova M, Deblois CL, et al. Assessing the impact of storage time on the stability of stool microbiota richness, diversity, and composition. Gut Pathog. 2021;13(75). doi:10.1186/s13099-021-00470-0
   PubMedGoogle Scholar
• Jung D-H, Chung W-H, Seo D-H, et al. Complete genome sequence of Bifidobacterium adolescentis P2P3, a human gut bacterium possessing strong resistant starch-degrading activity, 3. Biotech. 2020;10(2):31. doi:10.1007/s13205-019-2019-7
   Google Scholar
• Leggett RM, Alcon-Giner C, Heavens D, et al. Rapid MinION profiling of preterm microbiota and antimicrobial-resistant pathogens. Nat Microbiol. 2020;5(3):430–442. doi:10.1038/s41564-019-0626-z
   PubMed Web of Science ®Google Scholar
• Komiya S, Matsuo Y, Nakagawa S, et al. MinION, a portable long-read sequencer, enables rapid vaginal microbiota analysis in a clinical setting. BMC Med Genomics. 2022;15:68. doi:10.1186/s12920-022-01218-8
   PubMed Web of Science ®Google Scholar
• Pekmez CT, Dragsted LO, Brahe LK. Gut microbiota alterations and dietary modulation in childhood malnutrition—The role of short chain fatty acids. Clin Nutr. 2018;1–16. doi:10.1016/j.clnu.2018.02.014.
   Google Scholar